The US Food and Drug Administration has sent a warning letter to China-based Lepu Medical Technologies, roughly two months after the agency told health care providers and other stakeholders to stop using COVID-19 diagnostics made by the firm.
The warning letter, dated 29 July and posted online on 10 August, says Lepu Medical sold the Neutralization Antibody Test Kit, SARS-CoV-2 Antigen Rapid Test Kit, and Saliva Antigen...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?